Flu
As COVID-19 and its emerging variants continue to spread and the cold and flu season begins, hospitals and health systems are preparing early this year.
During 2020, the United States was in lockdown and taking precautions against COVID-19 during much of the flu season.
Now more than ever, hospitals and health systems need to encourage communities to stay healthy and protect themselves against the flu and COVID-19 by getting vaccinated and following recommended public health guidance to wear a mask, wash hands and socially distance.
The Centers for Disease Control and Prevention Sept. 9 from 2-3 p.m. ET will host a Clinician Outreach and Communication Activity webinar highlighting updates on Advisory Committee on Immunization Practices recommendations for the 2021-2022 influenza vaccination season.
The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.
To continue emphasizing the message of protecting against both the flu and COVID-19, AHA’s Wear A Mask and United Against the Flu campaigns released new resources, including new sample social media messages, several graphics and a video that hospitals and health systems can use to reiterate the…
This podcast, in support of AHA’s national strategic alliance with the National Urban League, is bringing attention to health inequities in Black and underserved communities through the lens of the ongoing COVID-19 public health emergency and this year’s flu season.
In this conversation, Elisa Arespacochaga, Interim Executive Lead, Institute for Diversity & Health Equity and Vice President, AHA Physician Alliance, talks with Andrea Custis, President and CEO, Urban League of Philadelphia, about health inequities in Black and underserved communities with a…
The Food and Drug Administration authorized the first prescription diagnostic test for both COVID-19 and influenza A and B that allows patients to collect a sample at home and ship it to a laboratory for analysis.
The Food and Drug Administration approved using the antiviral treatment Xofluza (baloxavir marboxil) to prevent flu in patients age 12 or older who have been exposed to someone with flu.